1 As filed with the Securities and Exchange Commission on June 29, 2001 ================================================================================ SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ---------- SCHEDULE 14D-9 (RULE 14D-101) SOLICITATION/RECOMMENDATION STATEMENT UNDER SECTION 14(D)(4) OF THE SECURITIES EXCHANGE ACT OF 1934 ---------- CARDIAC PATHWAYS CORPORATION (NAME OF SUBJECT COMPANY) CARDIAC PATHWAYS CORPORATION (NAME OF PERSON(s) FILING STATEMENT) COMMON STOCK, PAR VALUE $.001 PER SHARE (TITLE OF CLASS OF SECURITIES) 141408 10 4 (CUSIP NUMBER OF CLASS OF SECURITIES) 995 BENECIA AVENUE SUNNYVALE, CA 94086 (408) 737-0505 (ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF REGISTRANT'S PRINCIPAL EXECUTIVE OFFICES) ---------- THOMAS M. PRESCOTT PRESIDENT AND CHIEF EXECUTIVE OFFICER CARDIAC PATHWAYS CORPORATION 995 BENECIA AVENUE SUNNYVALE, CA 94086 (408) 737-0505 (NAME, ADDRESS, INCLUDING ZIP CODE, AND TELEPHONE NUMBER, INCLUDING AREA CODE, OF PERSON AUTHORIZED TO RECEIVE NOTICES AND COMMUNICATIONS ON BEHALF OF THE PERSON(S) FILING STATEMENT) ---------- Copies to: CHRIS F. FENNELL, ESQ. MICHAEL S. DORF, ESQ. CHRISTIAN E. MONTEGUT, ESQ. WILSON SONSINI GOODRICH & ROSATI PROFESSIONAL CORPORATION 650 PAGE MILL ROAD PALO ALTO, CA 94304 (650) 493-9300 ---------- [X] Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. ================================================================================ 2 ITEM 9. EXHIBITS Exhibits 1 Joint Press Release issued by Boston Scientific Corporation and Cardiac Pathways Corporation on June 29, 2001